Denali Capital Acquisition Corp.

Merged

CIK: 1913577•Ticker: DECA

Successfully merged with Longevity Biomedical, Inc • Now trading as

SPAC Overview

$75M

IPO Size

Completed

Current Status

2022

IPO Year

Timeline Progress

Investment Focus

Technology, Consumer, Hospitality

SPAC Team

Sponsors

Denali Capital Global Investments US Tiger Securities

Leadership

Chief Executive Officer and Director

Independent Director

Independent Director

Independent Director

Underwriters

US Tiger Securities EF Hutton Tiger Brokers (NZ)Joseph Gunnar

Key Information

IPO Date

April 8, 2022

Completion Date

January 10, 2024

Merger Target

Longevity Biomedical, Inc

SPAC Ticker

DECAU

External Resources

View Detailed Analysis